Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign L-AMB is a drug by @GileadSciences for kala azar (#NTDs) & Crypto Meningitis. It is too expensive for many countries. #AIDS2018 22:25 - 26 Jul 2018